Cambridge Cluster Investor Raises £75m To Fund UK Startups
Cambridge Innovation Capital, an investment firm focused on the University of Cambridge and the "Cambridge Cluster", has raised £75m for its healthcare fund in order to pursue new opportunities and expand its staff – a move highlighted as promising for the life sciences sector in the aftermath of Brexit.
You may also be interested in...
The UK Wellcome Trust Sanger Institute’s latest spin-out has received start-up funding to exploit more than six years of gut bacterial genome sequencing in order to develop novel bacteria-based therapies for a range of diseases.
The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.